JG
ABMD

Jefferies Group’s Abiomed Inc ABMD Stock Holding History

Jefferies Group’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-7,500
Closed -$1.86M – 2051
2022
Q2 		$1.86M Buy
+7,500
New +$2.02M 0.02% 634
2020
Q2 		– Sell
-2,500
Closed -$372K – 2188
2020
Q1 		$372K Buy
+2,500
New +$415K ﹤0.01% 1435
2018
Q4 		– Sell
-12,600
Closed -$5.67M – 2711
2018
Q3 		$5.67M Sell
12,600
-15,500
-55% -$6.11M 0.04% 486
2018
Q2 		$11.5M Buy
28,100
+3,000
+12% +$1.09M 0.06% 226
2018
Q1 		$7.3M Buy
+25,100
New +$6.36M 0.04% 341

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Winslow Capital Management
Winslow Capital Management Minneapolis, Minnesota $25.6B AUM 33.75% 1-Year Est. Return

Jefferies Group's ABMD Position: Q3 2021 in Review

Jefferies Group sold out of Abiomed Inc (ABMD) in Q3 2021, closing a stake of 5,010 shares — an estimated $1.56M sold.

Jefferies Group first reported a position in ABMD in Q1 2015 and held it in 15 quarters. The position peaked at $14.8M in Q2 2018. 498 funds tracked by Wall St. Rank hold ABMD as of Q3 2021.

  • Jefferies Group reported no remaining Abiomed Inc position as of Q3 2021 after selling out during the quarter.
  • Jefferies Group sold 5,010 Abiomed Inc shares in Q3 2021, an estimated $1.56M.
  • Jefferies Group first reported a position in Abiomed Inc in Q1 2015 and held it in 15 quarters.
  • Jefferies Group's Abiomed Inc position peaked at $14.8M in Q2 2018.
  • 498 funds tracked by Wall St. Rank held Abiomed Inc as of Q3 2021.

Based on Jefferies Group's 13F filing for Q3 2021, filed 15 Nov 2021.